2025-03-31 19:46:47
Latest Post
NHPC commissions 3 units of Parbati-II HE project
ixigo announces APRIL FULL REFUND SALE for 1st April - 100 Lucky Travellers To Win 100% Refund on Flight Bookings
Engineers India Ltd receives orders worth Rs. 245 crores
Blue Star appoints Mohit Sud as Group President, Unitary Cooling Products 
Jyoti Ltd receives Rs. 108.17 crores IT demand notice for AY 2020-21
Stock Report
Gujarat Themis Biosyn Ltd posts net profit of Rs. 9.78 crores in Q4 FY2022
Posted On : 2022-05-20 13:14:48( TIMEZONE : IST )
GUJARAT THEMIS BIOSYN LTD. has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 30.2724 crores during the period ended March 31, 2022 as compared to Rs. 19.2968 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 9.7888 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 7.1206 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 6.74 for the period ended March 31, 2022 as compared to Rs. 4.90 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 30.2724 crs | ₹19.2968 crs |  56.88% |
| Net Profit | ₹9.7888 crs | ₹7.1206 crs | 37.47% |
| EPS | ₹6.74 | ₹4.90 | 37.55% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 30.2724 crores during the period ended March 31, 2022 as compared to Rs.24.0938 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.9.7888 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.5.7907 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.6.74 for the period ended March 31, 2022 as compared to Rs.3.99 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 30.2724 crs | ₹24.0938 crs | 25.64% |
| Net Profit | ₹9.7888 crs | ₹5.7907 crs | 69.04% |
| EPS | ₹6.74 | ₹3.99 | 68.92% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.118.9040 crores during the Financial Year ended March 31, 2022 as compared to Rs.93.8293 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.43.6242 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.30.1797 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.30.03 for the Financial Year ended March 31, 2022 as compared to Rs.20.77 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹118.9040 crs | ₹93.8293 crs | 26.72% |
| Net Profit | ₹43.6242 crs | ₹30.1797 crs | 44.55% |
| EPS | ₹30.03 | ₹20.77 | 44.58% |
Shares of GUJARAT THEMIS BIOSYN LTD. was last trading in BSE at Rs. 434.30 as compared to the previous close of Rs. 428.45. The total number of shares traded during the day was 15500 in over 304 trades.
The stock hit an intraday high of Rs. 437.20 and intraday low of 406.95. The net turnover during the day was Rs. 6655033.00.
